Company Filing History:
Years Active: 2014-2018
Title: David M. Herman: Innovator in Neurodegenerative Disease Treatment
Introduction
David M. Herman is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of neurodegenerative diseases, particularly through his innovative approaches to treatment. With a total of 2 patents, his work focuses on improving the lives of those affected by conditions such as Friedreich's ataxia.
Latest Patents
Herman's latest patents include methods for treating Friedreich's ataxia using histone deacetylase inhibitors. This invention provides novel approaches to address the challenges posed by this debilitating condition. The methods outlined in his patents aim to enhance the therapeutic options available for patients suffering from Friedreich's ataxia and other related neurodegenerative or neuromuscular conditions.
Career Highlights
David M. Herman is affiliated with The Scripps Research Institute, where he conducts his research and development. His work at this esteemed institution has allowed him to collaborate with leading experts in the field, further advancing the understanding and treatment of neurodegenerative diseases.
Collaborations
Some of his notable coworkers include Joel M. Gottesfeld and Ryan Burnett. Their collaborative efforts have contributed to the innovative research and development of treatments for neurodegenerative conditions.
Conclusion
David M. Herman's contributions to the field of neurodegenerative disease treatment are noteworthy. His innovative patents and collaborations reflect his commitment to improving patient outcomes. Through his work, he continues to pave the way for advancements in medical science.